Walleye Trading LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Walleye Trading LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $1.16 Million - $1.56 Million	-50,300 Reduced 83.42%	10,000 $253,000
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $1.61 Million - $2.38 Million	58,800 Added 3920.0%	60,300 $1.86 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $355,496 - $649,572	-14,800 Reduced 90.8%	1,500 $60,000
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $209,436 - $434,124	12,400 Added 317.95%	16,300 $429,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $409,332 - $554,708	-30,800 Reduced 88.76%	3,900 $67,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $248,799 - $643,685	34,700 New	34,700 $575,000
Q2 2022 Aug 08, 2022	SELL	$5.21 - $12.14 $41,159 - $95,906	-7,900 Reduced 98.75%	100 $1,000
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $58,720 - $137,280	8,000 New	8,000 $81,000
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $893,107 - $1.22 Million	-19,055 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $8,596 - $11,827	-185 Reduced 0.96%	19,055 $1.16 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $1.07 Million - $1.39 Million	19,240 New	19,240 $1.19 Million

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.